Equities

AstraZeneca PLC

AZN:LSE

AstraZeneca PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10,062.00
  • Today's Change93.00 / 0.93%
  • Shares traded5.44m
  • 1 Year change-1.28%
  • Beta0.3964
Data delayed at least 20 minutes, as of Nov 21 2024 16:58 GMT.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue45,81144,35137,417
OPERATING EXPENSES
Cost of revenue total8,0688,6499,542
Selling, general and admin. expenses, total14,64913,51211,519
Depreciation/amortization3,8664,0943,044
Unusual expense(income)7235,0714,622
Other operating expenses, total41(344)(109)
Total operating expense37,61840,59436,361
Operating income8,1933,7571,056
Other, net(457)(441)(502)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6,8992,501(265)
Provision for income taxes938(792)(380)
Net income after taxes5,9613,293115
Minority interest(6)(5)(3)
Net income before extra. Items5,9553,288112
Total extraordinary items------
Net income5,9553,288112
Inc.avail. to common excl. extra. Items5,9553,288112
Inc.avail. to common incl. extra. Items5,9553,288112
EPS RECONCILIATION
Basic/primary weighted average shares1,5491,5481,418
Basic/primary eps excl. extra items3.842.120.08
Basic/primary eps incl. extra items3.842.120.08
Dilution adjustment------
Diluted weighted average shares1,5621,5601,427
Diluted eps excl. extra items3.812.110.08
Diluted eps incl. extra items3.812.110.08
COMMON STOCK DIVIDENDS
DPS - common stock primary issue2.902.892.84
Gross dividend - common stock4,4814,3643,856
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1,132889774
SUPPLEMENTAL INCOME
Depreciation, supplemental1,0081,098959
Total special items7235,0714,622
NORMALISED INCOME
Normalized income before taxes7,6227,5724,357
Effect of special items on income taxes1,3532,850780
Income tax excluding impact of special items2,2912,058400
Normalized income after tax5,3315,5143,957
Normalized income avail. to common5,3255,5093,954
Basic normalized EPS3.443.562.79
Diluted normalized EPS3.413.532.77
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.